Science, technology, engineering, and mathematics

Preemadonna's Ed-Tech Nailbot Ignites Girls' Interest in STEM

Retrieved on: 
Wednesday, November 8, 2023

CARLSBAD, Calif., Nov. 8, 2023 /PRNewswire/ -- Preemadonna - the inventor of Nailbot, the patented nail art printing system and creativity platform - is publicly debuting an educational kit version of Nailbot. The DIY Nailbot STEM Kit is a unique ed-tech STEM experience where users, primarily ages 10 and up, learn engineering principles and gain technical building skills to construct their own Nailbot nail art printer. This STEM Kit accelerates Preemadonna's mission to build connected creativity experiences to makers that are both fun and educational. 

Key Points: 
  • The DIY Nailbot STEM Kit is a unique ed-tech STEM experience where users, primarily ages 10 and up, learn engineering principles and gain technical building skills to construct their own Nailbot nail art printer.
  • Over the past six months, the DIY Nailbot STEM Kit has been piloted with STEM educators and pre-teen and teen ambassadors with rave reviews highlighting enhanced curiosity in STEM subjects among participants.
  • The DIY Nailbot STEM Kit is now available on Preemadonna's website for promotional early access pricing while supplies last.
  • Additional DIY Nailbot STEM Kits with new levels and engineering challenges are in development for a variety of skill and age levels.

STACK Infrastructure Partners with the Women’s Forum for the Economy and Society for Second Consecutive Year

Retrieved on: 
Tuesday, November 7, 2023

LONDON, Nov. 07, 2023 (GLOBE NEWSWIRE) -- STACK Infrastructure (“STACK”), the digital infrastructure partner to the world’s most innovative companies and a leading global developer and operator of data centers, today announced it will partner with the Women’s Forum for the Economy and Society (“Women’s Forum”) for the second year in a row.

Key Points: 
  • LONDON, Nov. 07, 2023 (GLOBE NEWSWIRE) -- STACK Infrastructure (“STACK”), the digital infrastructure partner to the world’s most innovative companies and a leading global developer and operator of data centers, today announced it will partner with the Women’s Forum for the Economy and Society (“Women’s Forum”) for the second year in a row.
  • This year, as a demonstration of its commitment to diversity, equity, and inclusion, STACK will sponsor and participate in the Women’s Forum 2023 Global Meeting, 28-29 November in Paris.
  • The Women’s Forum Global Meeting brings together leaders from around the world to highlight women's voices and perspectives on pressing global issues, ranging from sustainable development and economy to culture and media.
  • By supporting the Women’s Forum, we hope to encourage and attract more women to STACK, and to the technology sector as a whole.

First BRST Draws Attendees from Over 80 Countries to Boost Science and Tech Collaboration

Retrieved on: 
Tuesday, November 7, 2023

Chinese President Xi Jinping sent a congratulatory letter to the first BRST.

Key Points: 
  • Chinese President Xi Jinping sent a congratulatory letter to the first BRST.
  • Over 300 international guests from over 80 countries participated in the conference, including Nobel Prize winners, foreign academicians, experts, scholars, and presidents of well-known foreign universities.
  • The conference released the International Science and Technology Cooperation Initiative, advocating and practicing the concept of international science and technology cooperation that is open, fair, just and non-discriminatory, and working together to build a global science and technology community.
  • He foresees a future where robots specialized in data acquisition will create vast datasets for machine learning, significantly advancing material science.

Newly developed data infrastructure for accelerating Open Science through industry-university collaboration in Japan

Retrieved on: 
Tuesday, November 7, 2023

In recent years, universities and other research institutions have been strongly urged to promote Open Science enabling research data to be shared with society.

Key Points: 
  • In recent years, universities and other research institutions have been strongly urged to promote Open Science enabling research data to be shared with society.
  • This high-speed data transmission function allows massive amounts of research data to be rapidly shared among research groups.
  • The objective is to enable uploading large amounts of research data to a data aggregation platform from research groups and sharing the data among research groups instantaneously.
  • (3) Hideyuki Tanushi, Akihiro Yamashita, Takeo Hosomi, Yuta Namiki, Naoto Kai, Kanna Matsuura, and Susumu Date, "Campus Information Infrastructure Collaboration Supporting Research Data Management," Journal for Academic Computing and Networking.

CNL and AECL Continue to Expand Academic Partnership Through New Agreement with Queen’s University

Retrieved on: 
Tuesday, October 31, 2023

CHALK RIVER, Ontario, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Canadian Nuclear Laboratories (CNL), Canada’s premier nuclear science and technology laboratory, and Atomic Energy of Canada Limited (AECL), a federal Crown corporation with a mandate to drive nuclear opportunity for Canada, are pleased to announce that they have signed a Memorandum of Understanding (MOU) with Queen’s University to pursue collaborative research opportunities. The new agreement represents the seventh MOU signed between CNL, AECL and a growing list of Canadian universities, all of which are designed to cultivate closer relationships with Canada’s academic community, and to advance collaborative research in health and environmental sciences, clean energy, and safety and security.

Key Points: 
  • Under terms of the agreement, Queen’s will work in partnership with AECL and CNL to facilitate ongoing engagement between their respective researchers, pursue joint research projects, and enable knowledge mobilization in shared research areas of mutual interest.
  • “Along with AECL, CNL is thrilled to enter into this agreement with Queen’s University, a prestigious academic institution which is home to research programs and facilities that complement those at the Chalk River Laboratories campus,” commented Dr. Jeff Griffin, Vice-President of Science & Technology at CNL.
  • “In particular, CNL and Queen’s have areas of shared interest in our nuclear research programs, and this agreement will allow us to explore opportunities to combine resources and expand our research objectives.
  • “AECL recognizes that collaborating with one of Canada’s top universities is an opportunity to combine resources, expand research, and inspire the next generation of researchers, scientists, and technical experts.

Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in November

Retrieved on: 
Monday, October 30, 2023

Members of management will also be available for one-on-one meetings.

Key Points: 
  • Members of management will also be available for one-on-one meetings.
  • Stifel 2023 Healthcare Conference: Gwendolyn Binder, Ph.D., President of Science and Technology, will participate in a fireside chat on Tuesday, November 14, 2023 at 4:45 p.m.
  • 6th Annual Evercore ISI HealthCONx Conference: Steven Nichtberger, M.D., Chief Executive Officer, will participate in a fireside chat on Wednesday, November 29, 2023 at 8:20 a.m.
  • A live webcast of the presentations will be available on the News and Events section of the Company’s website at www.cabalettabio.com .

Cellares and Cabaletta Bio Partner to Evaluate Automated Manufacturing for CABA-201, Cabaletta’s CD19-CAR T Cell Therapy on Cellares’ Cell Shuttle Platform

Retrieved on: 
Monday, November 6, 2023

Cellares , the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, and Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies for patients with autoimmune diseases, today announced Cabaletta will evaluate Cellares’ automated manufacturing platform, the Cell Shuttle™, through Cellares’ Technology Adoption Partnership (TAP) program.

Key Points: 
  • Cellares , the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, and Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies for patients with autoimmune diseases, today announced Cabaletta will evaluate Cellares’ automated manufacturing platform, the Cell Shuttle™, through Cellares’ Technology Adoption Partnership (TAP) program.
  • Cellares’ innovative manufacturing technology transforms autologous and allogeneic cell therapy processes, covering nearly 90% of cell therapy modalities.
  • Through its TAP program, Cellares can facilitate the automation and tech transfer of manual processes onto the Cell Shuttle manufacturing platform in just six months.
  • With automation, standardization, and software-defined manufacturing (SDM), subsequent tech transfers become instant to any other Cell Shuttle in any IDMO Smart Factory worldwide.

Epirus Delivers IFPC-HPM Counter-Swarm System to U.S. Army, Developing Pathway to Field High-Power Microwave Capability

Retrieved on: 
Wednesday, November 1, 2023

LOS ANGELES, Nov. 1, 2023 /PRNewswire/ -- Epirus announced today the delivery of the first Indirect Fire Protection Capability – High-Power Microwave (IFPC-HPM) system to the U.S. Army. The IFPC-HPM is a Leonidas-derived counter-Unmanned Aerial System (C-UAS)-swarm capability – and this marks the first of four IFPC-HPM prototype systems Epirus will deliver to RCCTO, as part of a December 2022 contract award.

Key Points: 
  • First high-power microwave (HPM) prototype delivery opens pathway to bringing HPM capability to Air Defense community.
  • LOS ANGELES, Nov. 1, 2023 /PRNewswire/ -- Epirus announced today the delivery of the first Indirect Fire Protection Capability – High-Power Microwave (IFPC-HPM) system to the U.S. Army.
  • With our Army associates, the team at Epirus has developed and demonstrated unprecedented HPM capability in just nine months," said Ken Bedingfield, Chief Executive Officer, Epirus.
  • Epirus' HPM system has emerged as a leading capability from a crowded industry of kinetic and directed energy solutions to counter individual and swarm UAS.

Lakewood-Amedex Announces Leadership Changes

Retrieved on: 
Wednesday, November 1, 2023

UNIVERSITY PARK, Fla., Nov. 1, 2023 /PRNewswire/ -- Lakewood-Amedex Inc., a privately held, clinical-stage pharmaceutical discovery and development company advancing a broad portfolio of first-in-class antimicrobial and antifungal therapeutics called Bisphosphocins™, today announced that Peter B. Corr, Ph.D., who has served as board chairman since 2020, was named Executive Chairman and will assume the strategic responsibilities of former CEO Steve Parkinson who left the company at the request of the Board. Dr. Corr is the Co-founder and Managing General Partner of Auven Therapeutics Management LLLP. He retired from Pfizer Inc. in 2006 where he was Senior Vice President for Science and Technology, in addition to leading worldwide pharmaceutical research and development for Pfizer. Previously, Dr. Corr served as Executive Vice President, Pfizer Global Research & Development and President, Pfizer Worldwide Development. His full CV is on the Lakewood-Amedex website https://lakewoodamedex.com/about-us/board/

Key Points: 
  • Dr. Corr is the Co-founder and Managing General Partner of Auven Therapeutics Management LLLP.
  • Previously, Dr. Corr served as Executive Vice President, Pfizer Global Research & Development and President, Pfizer Worldwide Development.
  • His full CV is on the Lakewood-Amedex website https://lakewoodamedex.com/about-us/board/
    The Company also announced leadership promotions in the organization for Thomas Balzer, M.D., Ph.D., Senior Vice President for Clinical Development, and Kelvin Cooper, Ph.D., Vice President of Research and Development.
  • We look forward to their continued contributions as we work to advance our Research and Clinical Development programs."

The Department of Health - Abu Dhabi inaugurates a nationwide Clinical Genomic Medicine and Genetic Counselling programme for 100 Emirati Physicians

Retrieved on: 
Wednesday, November 1, 2023

ABU DHABI, UAE, Nov. 1, 2023 /PRNewswire/ -- In line with its continuous efforts to upskill the national healthcare workforce, the Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, has launched the Clinical Genomic Medicine and Genetic Counselling Programme for 100 Emirati physicians from different healthcare facilities across the UAE. The programme is offered by DoH, in partnership with the International Center for Genetic Disease (iCGD), Brigham and Women's Hospital, Harvard Medical School, and Khalifa University of Science and Technology, which hosted the inaugural ceremony. The programme is considered to be iCGD's largest and most comprehensive national genomics educational programmes, reflecting DoH's commitment to upskilling physicians in genomic medicine and equipping them with the necessary knowledge and skills.

Key Points: 
  • Dr. Noura Al Ghaithi, Undersecretary at the Department of Health – Abu Dhabi, Professor Sir John O'Reilly, President of Khalifa University, H.E.
  • Furthermore, it will enable participants to become proficient in diagnostics, clinical decision-making, and the analysis and interpretation of genomic data.
  • Through this, the programme will contribute to building the professional and genomic medicine capacity essential for the successful implementation of the Emirati Genome Programme.
  • Dr. Noura Al Ghaithi, Undersecretary at the Department of Health – Abu Dhabi said: "Abu Dhabi has positioned itself as the region's leading destination for healthcare and innovation in life sciences.